• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Application of physiologically-based pharmacokinetic modeling to explore the role of kidney transporters in renal reabsorption of perfluorooctanoic acid in the rat.应用基于生理学的药代动力学模型探究肾脏转运体在大鼠全氟辛酸肾重吸收中的作用。
Toxicol Appl Pharmacol. 2015 Dec 15;289(3):428-41. doi: 10.1016/j.taap.2015.10.017. Epub 2015 Nov 6.
2
Roles of organic anion transporters in the renal excretion of perfluorooctanoic acid.有机阴离子转运体在全氟辛酸肾排泄中的作用。
Basic Clin Pharmacol Toxicol. 2008 Jul;103(1):1-8. doi: 10.1111/j.1742-7843.2007.00155.x. Epub 2008 Jul 1.
3
Sex hormone-regulated renal transport of perfluorooctanoic acid.性激素调节的全氟辛酸肾脏转运
Chem Biol Interact. 2002 Mar 20;139(3):301-16. doi: 10.1016/s0009-2797(02)00006-6.
4
Roles of rat renal organic anion transporters in transporting perfluorinated carboxylates with different chain lengths.大鼠肾有机阴离子转运体在转运不同链长全氟羧酸中的作用。
Toxicol Sci. 2010 Feb;113(2):305-14. doi: 10.1093/toxsci/kfp275. Epub 2009 Nov 13.
5
Predicting tubular reabsorption with a human kidney proximal tubule tissue-on-a-chip and physiologically-based modeling.利用人源肾脏近端肾小管类器官芯片和基于生理学的模型预测管状重吸收。
Toxicol In Vitro. 2020 Mar;63:104752. doi: 10.1016/j.tiv.2019.104752. Epub 2019 Dec 17.
6
Binding of perfluorooctanoic acid to rat liver-form and kidney-form alpha2u-globulins.全氟辛酸与大鼠肝脏型和肾脏型α2u球蛋白的结合。
Drug Chem Toxicol. 2004 Nov;27(4):341-60. doi: 10.1081/dct-200039725.
7
Role of ABCB1 and ABCB4 in renal and biliary excretion of perfluorooctanoic acid in mice.ABCB1 和 ABCB4 在小鼠肾脏和胆汁中对全氟辛酸排泄的作用。
Environ Health Prev Med. 2024;29:21. doi: 10.1265/ehpm.23-00284.
8
Organic anion transporting polypeptide (Oatp) 1a1-mediated perfluorooctanoate transport and evidence for a renal reabsorption mechanism of Oatp1a1 in renal elimination of perfluorocarboxylates in rats.有机阴离子转运多肽(Oatp)1a1介导的全氟辛酸转运以及大鼠肾脏中Oatp1a1在全氟羧酸盐肾脏消除过程中的重吸收机制证据。
Toxicol Lett. 2009 Oct 28;190(2):163-71. doi: 10.1016/j.toxlet.2009.07.011. Epub 2009 Jul 16.
9
Uptake of perfluorooctanoic acid by Caco-2 cells: Involvement of organic anion transporting polypeptides.全氟辛酸在Caco-2细胞中的摄取:有机阴离子转运多肽的作用。
Toxicol Lett. 2017 Aug 5;277:18-23. doi: 10.1016/j.toxlet.2017.05.012. Epub 2017 May 25.
10
Male-dominant activation of rat renal organic anion transporter 1 (Oat1) and 3 (Oat3) expression by transcription factor BCL6.转录因子 BCL6 对雄性大鼠肾有机阴离子转运体 1(Oat1)和 3(Oat3)表达的雄性优势激活。
PLoS One. 2012;7(4):e35556. doi: 10.1371/journal.pone.0035556. Epub 2012 Apr 18.

引用本文的文献

1
Toxicokinetics and Perfluorooctanesulfonic Acid-Induced Liver Protein Expression Are Markedly Altered in Mice Lacking Albumin.在缺乏白蛋白的小鼠中,毒代动力学和全氟辛烷磺酸诱导的肝脏蛋白质表达显著改变。
Chem Res Toxicol. 2025 Jul 21;38(7):1183-1191. doi: 10.1021/acs.chemrestox.4c00508. Epub 2025 Jun 10.
2
Development of a Physiologically Based Pharmacokinetic (PBPK) Model for F-53B in Pregnant Mice and Its Extrapolation to Humans.建立 F-53B 在妊娠小鼠体内的生理药代动力学(PBPK)模型及其向人体的外推。
Environ Sci Technol. 2024 Oct 22;58(42):18928-18939. doi: 10.1021/acs.est.4c05405. Epub 2024 Oct 12.
3
Unbound Fractions of PFAS in Human and Rodent Tissues: Rat Liver a Suitable Proxy for Evaluating Emerging PFAS?人类和啮齿动物组织中全氟和多氟烷基物质的未结合分数:大鼠肝脏是否适合评估新兴全氟和多氟烷基物质?
Environ Sci Technol. 2024 Aug 20;58(33):14641-14650. doi: 10.1021/acs.est.4c04050. Epub 2024 Aug 6.
4
Evaluation of 14 PFAS for permeability and organic anion transporter interactions: Implications for renal clearance in humans.评估 14 种全氟和多氟化合物对通透性和有机阴离子转运体相互作用的影响:对人体肾清除率的意义。
Chemosphere. 2024 Aug;361:142390. doi: 10.1016/j.chemosphere.2024.142390. Epub 2024 May 25.
5
Parameter grouping and co-estimation in physiologically based kinetic models using genetic algorithms.基于遗传算法的生理动力学模型中的参数分组和共同估计。
Toxicol Sci. 2024 Jun 26;200(1):31-46. doi: 10.1093/toxsci/kfae051.
6
Binding of Per- and Polyfluoroalkyl Substances (PFAS) to Serum Proteins: Implications for Toxicokinetics in Humans.全氟和多氟烷基物质(PFAS)与血清蛋白的结合:对人体毒代动力学的影响。
Environ Sci Technol. 2024 Jan 16;58(2):1055-1063. doi: 10.1021/acs.est.3c07415. Epub 2024 Jan 3.
7
A State-of-the-Science Review of Interactions of Per- and Polyfluoroalkyl Substances (PFAS) with Renal Transporters in Health and Disease: Implications for Population Variability in PFAS Toxicokinetics.关于全氟和多氟烷基物质(PFAS)与健康和疾病中的肾脏转运蛋白相互作用的科学综述:对 PFAS 毒代动力学中人群变异性的影响。
Environ Health Perspect. 2023 Jul;131(7):76002. doi: 10.1289/EHP11885. Epub 2023 Jul 7.
8
Mechanistic Middle-Out Physiologically Based Toxicokinetic Modeling of Transporter-Dependent Disposition of Perfluorooctanoic Acid in Humans.基于机制的中观生理毒代动力学模型研究全氟辛酸在人体中的转运体依赖性处置过程。
Environ Sci Technol. 2023 May 2;57(17):6825-6834. doi: 10.1021/acs.est.2c05642. Epub 2023 Apr 18.
9
A Scoping Assessment of Implemented Toxicokinetic Models of Per- and Polyfluoro-Alkyl Substances, with a Focus on One-Compartment Models.全氟和多氟烷基物质已实施的毒物动力学模型的范围评估,重点是单室模型。
Toxics. 2023 Feb 9;11(2):163. doi: 10.3390/toxics11020163.
10
The Role of "Physiologically Based Pharmacokinetic Model (PBPK)" New Approach Methodology (NAM) in Pharmaceuticals and Environmental Chemical Risk Assessment.“生理药代动力学模型 (PBPK)”新方法学 (NAM) 在药品和环境化学风险评估中的作用。
Int J Environ Res Public Health. 2023 Feb 16;20(4):3473. doi: 10.3390/ijerph20043473.

本文引用的文献

1
Predicting carrier-mediated hepatic disposition of rosuvastatin in man by scaling from individual transfected cell-lines in vitro using absolute transporter protein quantification and PBPK modeling.通过使用绝对转运蛋白定量和生理药代动力学(PBPK)模型,从体外单个转染细胞系进行比例缩放,预测人瑞舒伐他汀的载体介导的肝脏处置。
Eur J Pharm Sci. 2014 Dec 18;65:156-66. doi: 10.1016/j.ejps.2014.09.007. Epub 2014 Sep 28.
2
In vitro and in vivo approaches to characterize transporter-mediated disposition in drug discovery.在药物发现中,采用体内外方法来表征转运体介导的药物处置。
Expert Opin Drug Discov. 2014 Aug;9(8):873-90. doi: 10.1517/17460441.2014.922540. Epub 2014 May 24.
3
Towards quantitation of the effects of renal impairment and probenecid inhibition on kidney uptake and efflux transporters, using physiologically based pharmacokinetic modelling and simulations.利用基于生理学的药代动力学建模与模拟,对肾功能损害和丙磺舒抑制作用对肾脏摄取和外排转运体的影响进行定量分析。
Clin Pharmacokinet. 2014 Mar;53(3):283-293. doi: 10.1007/s40262-013-0117-y.
4
Perfluorooctanoic acid (PFOA) exposures and incident cancers among adults living near a chemical plant.全氟辛酸(PFOA)暴露与居住在化工厂附近的成年人癌症发病情况。
Environ Health Perspect. 2013 Nov-Dec;121(11-12):1313-8. doi: 10.1289/ehp.1306615. Epub 2013 Sep 5.
5
Temporal trends of perfluoroalkyl concentrations in American Red Cross adult blood donors, 2000-2010.2000-2010 年美国红十字会成年献血者中全氟烷基浓度的时间趋势。
Environ Sci Technol. 2012 Jun 5;46(11):6330-8. doi: 10.1021/es300604p. Epub 2012 May 11.
6
Comparison and evaluation of pharmacokinetics of PFOA and PFOS in the adult rat using a physiologically based pharmacokinetic model.应用生理药代动力学模型比较和评估成年大鼠体内全氟辛酸(PFOA)和全氟辛烷磺酸(PFOS)的药代动力学。
Reprod Toxicol. 2012 Jul;33(4):452-467. doi: 10.1016/j.reprotox.2011.04.006. Epub 2011 May 4.
7
Comparative pharmacokinetics of perfluorononanoic acid in rat and mouse.氟壬酸在大鼠和小鼠体内的比较药代动力学。
Toxicology. 2011 Mar 15;281(1-3):48-55. doi: 10.1016/j.tox.2011.01.003. Epub 2011 Jan 13.
8
Characterization of cellular uptake of perfluorooctanoate via organic anion-transporting polypeptide 1A2, organic anion transporter 4, and urate transporter 1 for their potential roles in mediating human renal reabsorption of perfluorocarboxylates.通过有机阴离子转运多肽 1A2、有机阴离子转运体 4 和尿酸盐转运体 1 对全氟辛酸的细胞摄取进行表征,以研究它们在介导全氟羧酸的人体肾重吸收中的潜在作用。
Toxicol Sci. 2010 Oct;117(2):294-302. doi: 10.1093/toxsci/kfq219. Epub 2010 Jul 16.
9
Membrane transporters in drug development.药物开发中的膜转运体。
Nat Rev Drug Discov. 2010 Mar;9(3):215-36. doi: 10.1038/nrd3028.
10
Rate of decline in serum PFOA concentrations after granular activated carbon filtration at two public water systems in Ohio and West Virginia.俄亥俄州和西弗吉尼亚州两个公共供水系统进行颗粒活性炭过滤后血清全氟辛酸浓度的下降速率。
Environ Health Perspect. 2010 Feb;118(2):222-8. doi: 10.1289/ehp.0901252.

应用基于生理学的药代动力学模型探究肾脏转运体在大鼠全氟辛酸肾重吸收中的作用。

Application of physiologically-based pharmacokinetic modeling to explore the role of kidney transporters in renal reabsorption of perfluorooctanoic acid in the rat.

作者信息

Worley Rachel Rogers, Fisher Jeffrey

机构信息

Agency for Toxic Substances and Disease Registry, Division of Community Health Investigations, 4770 Buford Highway, Atlanta, GA 30341, United States; Interdisciplinary Toxicology Program, University of Georgia, 341 Pharmacy South, Athens, GA 30602, United States.

Interdisciplinary Toxicology Program, University of Georgia, 341 Pharmacy South, Athens, GA 30602, United States; Food and Drug Administration, National Center for Toxicological Research, 3900 NCTR Road, Jefferson, AR 72079, United States.

出版信息

Toxicol Appl Pharmacol. 2015 Dec 15;289(3):428-41. doi: 10.1016/j.taap.2015.10.017. Epub 2015 Nov 6.

DOI:10.1016/j.taap.2015.10.017
PMID:26522833
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4662604/
Abstract

Renal elimination and the resulting clearance of perfluorooctanoic acid (PFOA) from the serum exhibit pronounced sex differences in the adult rat. The literature suggests that this is largely due to hormonally regulated expression of organic anion transporters (OATs) on the apical and basolateral membranes of the proximal tubule cells that facilitate excretion and reabsorption of PFOA from the filtrate into the blood. Previously developed PBPK models of PFOA exposure in the rat have not been parameterized to specifically account for transporter-mediated renal elimination. We developed a PBPK model for PFOA in male and female rats to explore the role of Oat1, Oat3, and Oatp1a1 in sex-specific renal reabsorption and excretion of PFOA. Descriptions of the kinetic behavior of these transporters were extrapolated from in vitro studies and the model was used to simulate time-course serum, liver, and urine data for intravenous (IV) and oral exposures in both sexes. Model predicted concentrations of PFOA in the liver, serum, and urine showed good agreement with experimental data for both male and female rats indicating that in vitro derived physiological descriptions of transporter-mediated renal reabsorption can successfully predict sex-dependent excretion of PFOA in the rat. This study supports the hypothesis that sex-specific serum half-lives for PFOA are largely driven by expression of transporters in the kidney and contribute to the development of PBPK modeling as a tool for evaluating the role of transporters in renal clearance.

摘要

成年大鼠中,全氟辛酸(PFOA)经肾脏清除及其从血清中的清除呈现出明显的性别差异。文献表明,这在很大程度上是由于近端肾小管细胞顶端和基底外侧膜上有机阴离子转运体(OATs)的表达受激素调节,这些转运体促进了PFOA从滤液中排泄并重吸收进入血液。先前建立的大鼠PFOA暴露的生理药代动力学(PBPK)模型尚未针对转运体介导的肾脏清除进行具体参数化。我们建立了雄性和雌性大鼠PFOA的PBPK模型,以探讨Oat1、Oat3和Oatp1a1在PFOA性别特异性肾脏重吸收和排泄中的作用。这些转运体的动力学行为描述是从体外研究推断而来的,该模型用于模拟两性静脉内(IV)和口服暴露后的血清、肝脏和尿液随时间变化的数据。模型预测的雄性和雌性大鼠肝脏、血清和尿液中PFOA的浓度与实验数据吻合良好,表明体外推导的转运体介导的肾脏重吸收的生理学描述能够成功预测大鼠中PFOA的性别依赖性排泄。本研究支持以下假设:PFOA的性别特异性血清半衰期在很大程度上由肾脏中转运体的表达驱动,并有助于将PBPK建模发展为评估转运体在肾脏清除中作用的工具。